| Name | Title | Contact Details |
|---|---|---|
Anahita Anvari |
Corporate Counsel | Profile |
Rob Smith |
Vice President and Assistant General Counsel | Profile |
Lori Nickerson |
Senior Director, Senior Corporate Counsel - Operations and Shared Services | Profile |
Anne Liddy |
Vice President and Assistant General Counsel | Profile |
Starkey Hearing Technologies is a privately held, global hearing technology company headquartered in Eden Prairie, Minn. We are recognized for our innovative design, development and distribution of comprehensive digital hearing systems. We develop products using an evidence-based design approach, meaning that rigorous testing takes place to prove the benefits of a new technology or algorithm before a hearing aid is ever fit on a patient. Every Starkey Hearing Technologies employee is committed to helping people on their journey to better hearing every day. Starkey Hearing Technologies operates 21 facilities and conducts business in more than 100 markets worldwide. We develop, manufacture and distribute hearing aids via three distinct brands - Audibel, NuEar and our original brand, Starkey.
accurate medical & pharmacy is a Fort Worth, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Casana is changing the way healthcare does business with a smart toilet seat that enables effortless, integrated, and consistent in-home health monitoring. The Heart Seat™ captures key clinical measurements, including heart rate, blood pressure, and blood oxygenation, to assist medical teams with monitoring chronic conditions beyond the four walls of the hospital. The healthcare system has been searching for this actionable intelligence for decades, and it turns out, we were sitting on a great idea all along.
Biosystems of New England is a Waltham, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Vermillion`s vision is to become a recognized leader in the advancement of women`s health by providing innovative methods to detect, monitor and manage the treatment of gynecologic cancers and other related diseases. We will develop and commercialize high-value, multi-marker, diagnostic tests which address unmet needs in gynecologic oncology and women’s health. We will accomplish our mission through internal development, targeted acquisitions, and collaborations with leading scientific and clinical institutions. Our global commercial efforts will include direct marketing and sales activities as well as partnerships with leading companies in women’s health.